Traditional Rx-to-OTC switch strategies are being redefined across Europe and the UK. Regulatory expectations are shifting, and Real-World Evidence (RWE) is playing an increasingly central role in switch approvals.
Join IQVIA Consumer Health and the AESGP on April 21 for a live webinar exploring how the next generation of switch strategies in the UK and the EU is taking shape. During this free session, we’ll cover:
Click the Register button to secure your place.
Vice President, Global R&D/RWE Services, IQVIA Consumer Health
Associate Director, Global R&D/RWE Services & Thought Leadership, IQVIA Consumer Health
Principal, Strategy/Life Sciences (US), IQVIA
Senior Regulatory Science and Strategy Lead, AESGP
Associate Director, Global Marketing, IQVIA Consumer Health
Shape the future of consumer health.
Compelling claims to capture the minds of consumers
Navigate regulatory pathways with confidence
.svg){kind=icon}
